Novyra Pharmachem Balance Sheet

Financials in millions INR. Fiscal year is April - March.

Millions INR. Fiscal year is Apr - Mar.

Fiscal Year	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Mar '26 Mar 31, 2026	Mar '25 Mar 31, 2025	Mar '24 Mar 31, 2024	Mar '23 Mar 31, 2023	Mar '22 Mar 31, 2022
Property, Plant & Equipment	7.41	49.29	50.62	50.81	51
Cash & Equivalents	1.77	2.63	0.85	2.21	0.77
Accounts Receivable	0.11	0.6	1.4	1.42	0.79
Investment In Debt and Equity Securities	-	0.04	-	-	-
Other Current Assets	5.6	-	0.06	0.06	0.2
Other Long-Term Assets	-	9.18	8.26	7.91	9.39
Total Assets	14.89	61.74	61.19	62.42	62.15
Accounts Payable	8.23	-	0.69	-	-
Accrued Expenses	-	-	-	0.56	0.4
Other Current Liabilities	0.43	1.78	0.23	-	-
Other Long-Term Liabilities	-0	-0	1	1	1
Total Liabilities	8.67	1.78	1.92	1.56	1.4
Common Stock	63.3	63.3	61.98	61.98	61.98
Retained Earnings	-57.08	-3.34	-2.71	-1.11	-1.23
Shareholders' Equity	6.22	59.96	59.27	60.86	60.75
Total Liabilities & Equity	14.89	61.74	61.19	62.42	62.15
Net Cash (Debt)	1.77	2.63	0.85	2.21	0.77
Net Cash (Debt) Growth	-32.73%	209.88%	-61.62%	188.85%	-28.29%
Net Cash Per Share	0.28	0.41	0.14	0.36	0.12
Filing Date Shares Outstanding	6.33	6.28	6.2	6.2	6.2
Total Common Shares Outstanding	6.33	6.28	6.2	6.2	6.2
Book Value Per Share	0.98	9.56	9.56	9.82	9.80
Tangible Book Value	6.22	59.96	59.27	60.86	60.75
Tangible Book Value Per Share	0.98	9.56	9.56	9.82	9.80
Land	-	-	6.63	6.63	6.63
Buildings	-	-	2.05	2.05	2.05